BODI vs MAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 03, 2026

BODI

61.1
AI Score
VS
BODI Wins

MAX

39.8
AI Score

Investment Advisor Scores

BODI

61score
Recommendation
STRONG BUY

MAX

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric BODI MAX Winner
Forward P/E 5.4735 8.8574 BODI
PEG Ratio 0 0 Tie
Revenue Growth -22.4% 22.7% MAX
Earnings Growth 0.0% 75.4% MAX
Tradestie Score 61.1/100 39.8/100 BODI
Profit Margin 5.7% 8.3% MAX
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY EXTENDED BODI

Relative Price Performance (Last 90 Days)

BODI 1M: -12.0% · 3M: -61.2% MAX 1M: +57.2% · 3M: +22.9%

Current Technical Phase

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.3%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $4.24

MAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 77.5 · Price: $15.15

Fundamentals Snapshot

Metric BODI MAX
Market Cap — —
Forward P/E -31.2 8.3
Trailing P/E 2.4 8.1
Revenue (TTM) — —
Revenue Growth -0.2% 0.2%
Gross Margin 0.7% 0.1%
Operating Margin 0.0% 0.1%
EPS 1.73 1.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.